Hospitals
Advanced diagnostic and chronic care solutions for clinical departments and inpatient programmes.
Clinical-Grade MedTech · Built for Institutions
Closing the Gaps in Chronic Care — Detection, Adherence, Outcomes
Purpose-built medical devices for hospitals, diagnostic centres, and care networks. Actively deployed across clinical settings.
41K+
Doses Monitored
800+
Patients Assessed
6+
Govt. Grants
3
Patents Granted
CDSCO
License
Comprehensive Chronic Care
Early Detection
PoC Autonomic Neurofunction testing with Instant, Clinically Actionable Reports
Smart Adherence
Dose-level Medication Tracking with Real-time Alerts and Adherence Logging
Clinical Grade
Clinically Aligned & Standardized Autonomic Neurofunction Assessment
Remote Monitoring
Continuous Adherence visibility with Timely Caregiver Notifications
Institutional Care
Who We Serve
Supporting institutions across the continuum of chronic care.
Diagnostic Centres
Point-of-care autonomic assessment and preventive cardiovascular screening capabilities.
Diabetes Clinics
Early identification of autonomic dysfunction and cardiovascular risk in diabetic patients.
Home Healthcare Providers
Medication adherence monitoring and remote caregiver visibility for distributed care programmes.
Senior Living Facilities
Long-term chronic disease management and 24/7 adherence visibility for residential care settings.
Research Institutions
Standardised autonomic function data and HRV analytics for clinical research and academic studies.
Our Methodology
The Inovocare Approach
Bridging the gap between detection and adherence for better patient outcomes
Early Detection
Cardiac Autonomic Dysfunction often goes unnoticed until Complications arise. Our Point-of-Care Autonomic Neurofunction testing enables early identification of Cardiovascular Risk through standardized Protocols.
- Non-invasive Autonomic Assessment
- HRV based and Baro-Reflex linked Analysis
- Instant, Clinically Interpretable Reports
Consistent Adherence
Medication failure in Chronic Care is driven by missed or incorrect Dosing. Our system ensures dose-level Adherence through automated Monitoring and Real-time Tracking of scheduled doses.
- Scheduled Dose Reminders with Confirmation
- Dose-by-dose Adherence logging
- Live Caregiver Alerts and Escalation
Detection + Adherence = Better Outcomes
Inovocare addresses Two Silent but Critical Gaps in Chronic Care—Early Detection of Autonomic Dysfunction and Consistent Medication Adherence—Reducing Complications and Improving Long-Term Outcomes.
Built for Healthcare
Why Inovocare
Most MedTech reaches hospitals as imported equipment with limited local support, slow service cycles, and no adaptation to Indian clinical workflows. Inovocare builds differently — devices designed from the ground up for Indian clinical environments, regulatory pathways, and care economics.
Both products are active in clinical and home settings, backed by government grants, and supported by a team that answers calls, not tickets.
Clinically validated, not lab-only
Both NIBRA-CS® and MedpeR® have been tested in real clinical environments — not just controlled trials. Real patients, real workflows, real data informing every product decision.
Regulatory-ready for Indian procurement
CDSCO licensed, Made in India, backed by DST and DBT grants. Procurement teams can move from evaluation to purchase order without regulatory red tape.
A team that deploys, trains, and supports
Institutional deployment includes on-site setup, staff training, and ongoing support — not a courier box and a PDF manual. We stay engaged through the operational life of every deployment.
Our Products
Two Devices. One Clinical Mission.
Detect autonomic dysfunction earlier. Close the medication adherence gap. Both deployable in institutional and home settings.
Detection and adherence are where chronic disease management most often breaks down — a problem caught too late, or treatment that quietly stops working. NIBRA-CS® finds autonomic dysfunction earlier. MedpeR® makes sure the treatment that follows is actually taken.
For Care Facilities & Home Use
MedpeR®
Smart Medication Adherence Device
Non-adherence to prescribed medication is responsible for nearly 50% of chronic disease complications. MedpeR® addresses this at the dose level — tracking each compartment opening, alerting patients and caregivers when doses are missed, and giving clinicians an adherence record that reflects actual patient behaviour, not self-reporting.
Dose-Level Tracking with Audible Alerts
Each compartment is monitored independently. Audible and push alerts fire at scheduled dose times — and escalate to caregiver or nursing staff if the dose is not taken within a defined window.
Adherence Reports for Clinical Review
Timestamped adherence logs accessible via the MedpeR dashboard — giving treating physicians objective data on patient compliance at every follow-up visit, not patient recall.
MedpeR Network — Multi-Patient Facility Dashboard
Care facilities managing multiple patients can monitor all enrolled patients from a single dashboard — real-time status, missed dose alerts, and adherence trends across the entire resident or patient population.
For Hospitals, Diagnostic Centres & Neurology Departments
NIBRA-CS®
NCS-3.0 · Non-Invasive Baro Reflex Assessment - Combined System
Autonomic dysfunction underlies a broad spectrum of chronic conditions — from diabetic neuropathy and Parkinson's disease to hypertension and post-COVID dysautonomia — yet most clinical settings lack a practical tool to assess it. NIBRA-CS® delivers a complete autonomic function profile in 19 minutes + prep time, producing standardised reports that match international clinical guidelines, without invasive instrumentation or a specialist operator.
6 Autonomic Function Tests in One Session
Resting ECG, deep breathing test, Valsalva manoeuvre, response to standing test, postural hypotension test, and sustained handgrip test — plus a complementary 5-minute HRV recording — all performed non-invasively with a single device, producing a structured clinical report.
Point-of-Care — No Specialist Operator Required
Designed for real clinical throughput — a trained technician can run the full test battery. No need for a neurologist or cardiologist to be present during the assessment itself.
CDSCO Licensed · Procurement-Ready
Holds a valid CDSCO medical device licence. Eligible for institutional procurement through government tender and GeM channels. Documentation available for biomedical and purchase committees.
Use Cases
Clinical Applications
Supporting preventive and connected healthcare across specialties.
NIBRA-CS®
Diabetic Neuropathy Screening
Cardiac Autonomic Neuropathy (CAN) affects up to 20% of diabetic patients yet remains underdiagnosed. NIBRA-CS® enables standardised autonomic reflex testing at point-of-care, providing clinically interpretable reports in 19 minutes + prep time — without invasive procedures.
Learn about NIBRA-CS®NIBRA-CS®
Preventive Cardiology
Autonomic dysfunction precedes overt cardiovascular disease by years. NIBRA-CS® provides baroreflex sensitivity and HRV-based cardiovascular risk stratification, enabling proactive clinical decisions before complications arise.
Learn about NIBRA-CS®
MedpeR®
Home-Based Chronic Care
Chronic disease management extends far beyond the clinic. MedpeR® brings dose-level adherence monitoring into the home, giving caregivers and providers real-time visibility without requiring patients to travel or self-report.
Learn about MedpeR®MedpeR®
Post-Hospital Discharge Programs
The 30 days following discharge are the highest-risk period for medication non-adherence and readmission. MedpeR® provides structured adherence support and automated alerts during this critical transition window.
Learn about MedpeR®
MedpeR®
Senior Living Communities
Multi-resident facilities managing complex medication schedules across dozens of patients can use MedpeR® to monitor adherence at scale — with a single facility dashboard showing real-time status for every enrolled resident.
Learn about MedpeR®NIBRA-CS®
Research Applications
NIBRA-CS® produces structured, standardised HRV and baroreflex datasets suitable for longitudinal studies, epidemiological research, and clinical trials. Already used in pilot studies at leading Indian research institutions.
Learn about NIBRA-CS®
Real-World Results
Measurable Impact
Our solutions are actively deployed and making a difference in patients' lives
MedpeR® Impact
0+
Medication Doses Monitored
Based on real patient adherence data across active deployments, demonstrating consistent usage and reliability in real-world conditions.
640K+
Patient-Hours monitored
24/7
Monitoring
NIBRA-CS® Impact
0+
Patients Assessed
Across clinical trials and pilot deployments in real healthcare environments, providing critical cardiovascular autonomic neurofunction insights along with heart rate variability.
19 min
Test Duration
100%
Non-Invasive
6+
Govt. Grants
6+
Healthcare Partners
3
Patents Granted
2
CDSCO License
Standards & Assurance
Regulatory & Quality
Built with a commitment to clinical excellence and institutional accountability.
🏛️
Regulatory & Quality Standards
CDSCO Licensed Devices
Both NIBRA-CS® (CDSCO Class B, MD5) and MedpeR® (CDSCO Class A, NSNM) hold valid Central Drugs Standard Control Organisation licences — mandatory regulatory clearance for medical devices sold and deployed in India. Procurement-ready for hospital and government tenders.
3 Granted Patents
Core technology protected by three granted patents — a utility patent and a design patent for MedpeR®, and a granted patent for NIBRA-CS® — covering device architecture and clinical assessment methodology, demonstrating genuine technical innovation rather than adaptation of existing systems.
6+ Government Grants
Recognised and funded by leading national science and technology bodies including DST, DBT, and BIRAC — validating the clinical significance and innovation quality of both platforms.
Clinical Collaborations
Technology validated through pilot deployments and collaborative studies with hospitals and academic medical institutions across India — real-world evidence underpinning both products.
Incubated at IIM Calcutta Innovation Park
IIMCIP incubation provides institutional credibility, mentorship, and business development support — placing Inovocare within one of India's most respected healthcare and technology innovation ecosystems.
Made in India
Designed, engineered, and manufactured entirely in India — aligned with national healthcare self-reliance initiatives and eligible for government procurement preference under Make in India guidelines.
Recognition & Clinical Validation
Trust & Institutional Ecosystem
Backed by national institutions, funded by government bodies, and validated through real clinical environments.
Incubation & Funding Partners
Recognised and funded by leading national science, technology, and innovation bodies — including the Biotechnology Ignition Grant (BIG), AGC-JanCARE, and NIDHI PRAYAS programmes supporting NIBRA-CS® from prototype to market.
Clinical & Research Collaborations
Validated through clinical pilots and research partnerships with leading hospitals and academic medical institutions — including a peer-reviewed randomized controlled trial (Public Health Discourse, 2024) and multi-site, ethics-committee-approved studies.
Meet The Team
Experts Driving Innovation
A multidisciplinary team combining clinical expertise with cutting-edge engineering
Information Centre
Resources
Product and technical information for healthcare institutions.
MedpeR®
Product Brochure
Overview of MedpeR® features, clinical applications, and deployment models for care facilities and home use.
Request BrochureNIBRA-CS®
Product Brochure
Clinical overview of NIBRA-CS® — autonomic function tests performed, report structure, setup requirements, and institutional deployment options.
Request BrochureNIBRA-CS®
Technical Datasheet
Full technical specifications, hardware parameters, regulatory certifications, and integration requirements for procurement and biomedical teams.
Request Datasheet
Work With Us
Get in Touch
Whether you're evaluating a deployment or have a support query — here's the right path.
Institutional Enquiry
Demo requests, procurement evaluation, pilot deployments, clinical collaborations, and bulk orders. Direct line: partnerships@inovocare.in
🏢 Our Products
Based in Kolkata, India
Incubated at IIM Calcutta Innovation Park. Serving institutions across India.
Institutional enquiries: partnerships@inovocare.in